University of Louisville: Building an evidence-based algorithm to guide autoimmune neurology patient care

Hannah Crawford — Mon, 15 Mar 2021 11:45:00 +0000

UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the right diagnosis for patients.

The post University of Louisville: Building an evidence-based algorithm to guide autoimmune neurology patient care appeared first on Insights.

Updated testing algorithms for plasma cell proliferative disorders [Test in Focus]

Samantha Rossi — Tue, 15 Dec 2020 13:25:00 +0000

Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as multiple myeloma. Based on recently published data, the new testing algorithms focus on use of fluorescence in situ hybridization (FISH) panels, rather than chromosome studies.

The post Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] appeared first on Insights.

Cut Costs Archives - Insights

University of Louisville: Building an evidence-based algorithm to guide autoimmune neurology patient care

Updated testing algorithms for plasma cell proliferative disorders [Test in Focus]